Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings' Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 65.66% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 65.66% YoY), while the FY2025 annual figure was $1.2 million, up 33.45% from the prior year.
• Other Non-Current Liabilities was $1.5 million for Q1 2026 at Organogenesis Holdings, up from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $3.0 million in Q2 2025 to a low of $894000.0 in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $1.4 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities plunged 71.27% in 2022, then jumped 138.33% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $1.1 million in 2022, then advanced by 8.11% to $1.2 million in 2023, then retreated by 26.3% to $894000.0 in 2024, then jumped by 33.45% to $1.2 million in 2025, then gained by 24.56% to $1.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.5 million (Q1 2026), $1.2 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.